In two recent cases, the Federal Circuits held that claim amendments at issue were “tangential” to the “equivalent” at issue, and upheld findings of infringement. The case details are below:  Case #1: Ajinomoto Co. v. ITC  The claim amendment at issue related to an encoding nucleotide sequence. The original claim language recited “a protein which […]